• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Pear Therapeutics inks multiple agreements to expand digital therapeutic platform

April 6, 2021 By Sean Whooley

Pear TherapeuticsPear Therapeutics announced today that it entered into multiple agreements to bolster its prescription digital therapeutics (PDT) platform.

Boston-based Pear Therapeutics’ agreements are set to add to its library of digital biomarkers, machine learning algorithms, sensor-based technologies and digital therapeutics, according to a news release.

The agreements have been struck with technology companies including Empatica, etectRx and KeyWise as Pear Therapeutics seeks to build a comprehensive product offering for remote sensing, real-time personalization of digital therapeutic content and pharmaceutical dosing and overall enhanced patient outcomes.

Empatica develops medical wearables and digital biomarkers. The agreement will allow Pear to explore using the sensors to evaluate withdrawal symptoms in patients with substance use disorder, opioid use disorder and alcohol use disorder.

The agreement with etectRx will explore the development of digital therapeutics combined with digital pills, using etectRx’s FDA-cleared ID-Cap digital pill system. ID-Cap is an ingestible event marker designed to guide digital, patient-centric and value-based therapeutic interventions.

Finally, the deal with KeyWise is set to help Pear build capabilities to track and produce individualized mental health metrics with natural language processing PDTs through an artificial intelligence-enabled keystroke detection algorithm developed by KeyWise and licensed by Pear.

“We are excited to announce these agreements, which expand the leading PDT platform and create optionality as the space grows beyond neurobehavioral therapies,” Pear president & CEO Dr. Corey McCann said in the release. “Accessing external technologies allows us to build PDTs with new capabilities and continue to broaden their scope and effectiveness. With the ability to collect and quantify information in real-world settings and to potentially personalize products in real-time, PDTs present the opportunity to truly revolutionize healthcare.”

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Neurological, Patient Monitoring, Pharmaceuticals Tagged With: Empatica, etectrx, KeyWise, peartherapeutics

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS